• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Fitbit Data Suggests People with COVID-19 Experience Lingering Health Effects

Share:

July 16, 2021

New research published this week in JAMA Network Open is the latest to indicate that some people experience lingering symptoms of COVID-19 months after recovering.

The data comes out of the DETECT (Digital Engagement and Tracking for Early Control and Treatment) study, which collects health data from different wearables – such as Fitbits, Apple Watches, Garmins, Oura Rings, or any others that can share data with Google Fit or Apple HealthKit – to understand individual changes associated with a viral illness, including COVID-19.

This portion of the study analyzed 875 Fitbit users who reported symptoms of an acute respiratory illness and underwent COVID-19 testing. It compared their wearable data from baseline through illness and back to baseline to see how COVID-19 affected recovery.

TOP-LINE DATA

Individuals with COVID-19 took longer to return to their resting heart rate, sleep, and activity baselines than those with symptoms who tested negative. On average, people with COVID-19 experienced lingering physiological effects for two to three months, with some taking much longer to return to normal.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

COVID-19-positive participants tended to experience a dip in resting heart rate at the onset of symptoms, followed by a prolonged period of elevated heart rate that lasted an average of 79 days. However, a small subset of participants (13.7%) experienced a higher-than-normal resting heart rate for more than 133 days.

Step count and sleep amount returned to baseline faster than resting heart rate at 32 and 24 days, respectively.

The study also collected symptom data in the early stages of illness and found that COVID-19-positive individuals experienced higher frequencies of cough, body aches, and shortness of breath.

The researchers note that only monitoring symptoms at the onset of illness could be a possible limitation of the study because they couldn’t compare long-term physiological changes with long-term symptoms.

Despite that, the researchers believe that people who have worse symptoms early on and who experience larger disturbances in their heart rate take longer to recover.

METHODS

Out of the 875 individuals in the study, 234 tested positive for COVID-19 and 641 tested negative.

In the positive group, the average age was 45.3 years and the majority (70.9%) identified as female. Similarly, the average age in the negative group was 44.7 years and most (71.1%) were women.

The research was headed by a team from the Scripps Research Translational Institute.

THE LARGER TREND

The DETECT study kicked off last March, with a goal of identifying areas with viral outbreaks such as COVID-19 more quickly and using person-specific vital signs to create more individualized approaches to healthcare. So far, more than 38,000 people have contributed their data to the study.

Previous findings from the study show that pairing data collected by wearables with self-reported symptoms could improve COVID-19 prediction.

Around the same time the DETECT study launched, UC San Francisco began its TemPredict Study, which uses data from Oura Rings to predict and track COVID-19. Early results from the study indicate that the temperature data collected by the Oura Ring was able to reliably detect the onset of fevers, one of the most common symptoms associated with COVID-19 and the flu.

Fitbit has been a major contributor to COVID-19 research and previously conducted studies to develop an algorithm for early detection of COVID-19 and to predict the severity of illness, symptom prevalence, illness duration, and likelihood of hospitalization. It also published data on sleeping habits during the pandemic and recently partnered with Stanford Medicine to study COVID-19 spread among college athletes.

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Eliminating the Long, Cumbersome and Costly Diagnosis of Genetic DiseasesEliminating the Long, Cumbersome and Costly Diagnosis of Genetic Diseases
  • iRhythm Unveils $13M Verily Afib Deal, Readies $100M OfferingiRhythm Unveils $13M Verily Afib Deal, Readies $100M Offering
  • Senators Petition Congress for Additional $2B Toward Broadband, TelehealthSenators Petition Congress for Additional $2B Toward Broadband, Telehealth
  • Microsoft Healthcare reveals more of its strategy with new cloud and AI products for hospitalsMicrosoft Healthcare reveals more of its strategy with new cloud and AI products for hospitals
  • Aceto Acquires Syntor Fine ChemicalsAceto Acquires Syntor Fine Chemicals
  • Flow launches at-home depression headset and therapy app in the U.K.Flow launches at-home depression headset and therapy app in the U.K.
  • Olive Lands $51M to Power AI-Powered Digital Employee PlatformOlive Lands $51M to Power AI-Powered Digital Employee Platform
  • EQT and CPPIB to acquire a Majority Equity Stake in Waystar in Transaction Valued at $2.7 BillionEQT and CPPIB to acquire a Majority Equity Stake in Waystar in Transaction Valued at $2.7 Billion

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications